Tech Transfer Central
Technology Transfer Tactics

Technology Transfer Tactics, December 2022


Technology Transfer Tactics, December 2022The following is a list of the articles that appear in the December 2022 issue of Technology Transfer Tactics monthly newsletter.

If you are already a current subscriber click here to log in and access your issue.

Not a subscriber already? Subscribe now and get access to this issue as well as access to our online archive of back issues, industry research reports, sample MTAs, legal opinions, sample forms and contracts, government documents and more!

Technology Transfer Tactics
Vol. 16, No. 12, December 2022

  • As litigation funding gains acceptance, universities may seek more infringement cases. More universities are taking advantage of litigation funding for patent infringement cases, even as there are growing questions about how unfavorably courts and others might view this strategy.
  • Vanderbilt’s ‘peer-to-peer’ Innovation Ambassadors puts faculty on TTO team. Vanderbilt University has launched what it calls the Innovation Ambassadors program — a volunteer initiative in which each department has a faculty member who serves as a liaison between researchers and innovation programs across campus. At the heart of the program is “peer to peer counseling and advising,” says Alan Bentley, assistant vice chancellor, who heads up the Center for Technology Transfer & Commercialization.
  • At the big football game, BYU and Notre Dame start-ups score with investors. The University of Notre Dame football team headed to Las Vegas’ Allegiant Stadium this past October for its 2022 Shamrock Series game against BYU. Since 2009, this beloved series has brought the home football game experience to a neutral location and acts as a bowl game of sorts for players and fans. This year’s game had a little twist: it also served as a venue for giving start-ups from the two schools some great exposure.
  • FTO analysis: A prudent step to mitigate patent infringement liability. For many TTOs, conducting a freedom-to-operate analysis to ensure a clear path to commercialization is an expensive proposition that is not a regular part of their IP-related due diligence. But in many cases it should be, and neglecting an FTO analysis can cost you in the long run. In a classic “penny wise, pound foolish” calculation, TTOs that overlook this fundamental safeguard could find themselves doing damage control.
  • Milestone-driven funding for early technologies gets a DEI twist at Mount Sinai. When it comes to encouraging diversity in tech transfer activity, sometimes it seems like there’s more talk than action – but not for Mount Sinai Innovation Partners (MSIP), which is putting its money where its mouth is.
  • CROs gaining bigger role in TTOs’ life science commercialization plans. In life sciences commercialization, tech transfer offices have become much more willing to bring drug candidates further forward to de-risk the IP for potential licensees, while drug-focused university start-ups also face hurdles in the development process that can make or break their futures. For both those reasons, contract research organizations (CROs) are becoming a bigger, and often critical, TTO partner.

Posted December 14th, 2022